A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Impact of Evolocumab on Major Cardiovascular Events in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

Project: Research

StatusActive
Effective start/end date24/10/1923/10/24

Keywords

  • clinical trial
  • treatment efficacy
  • cardiovascular risk
  • treatment safety